Quantcast

Inhibition of myofibroblastic transformation of cultured rat hepatic stellate cells by methylxanthines and dibutyryl cAMP

Research paper by Norifumi Kawada, Tetsuo Kuroki, Kenzo Kobayashi, Masayasu Inoue, Kenji Kaneda

Indexed on: 01 May '96Published on: 01 May '96Published in: Digestive Diseases and Sciences



Abstract

Stellate cells isolated from rat liver and cultured on uncoated plastic plates in serumcontaining medium started proliferating and transforming to myofibroblastic cells. However, stellate cells did not proliferate when cultured in the presence of 3-isobutyl-1-methylxanthine or dibutyryl cAMP (dBcAMP). These substances significantly reduced [3H]thymidine incorporation of the proliferating cells. Morphologically, stellate cells cultured in the presence of 3-isobutyl-1-methylxanthine or dibutyryl cAMP kept well-developed processes and lipid droplets while untreated cells exhibited myofibroblastic characteristics. Western blot analysis and immunocytochemical studies revealed that 3-isobutyl-1-methylxanthine and dBcAMP suppressed the expression ofα-smooth muscle actin in stellate cells. 3-isobutyl-1-methylxanthine increased the cellular levels of cAMP from a basal value of 0.7 ± 0.1 to 8.5 ± 1.7 pmol/well in stellate cells. Thus, 3-isobutyl-1-methylxanthine and dBcAMP inhibit the myofibroblastic transformation of stellate cellsin vitro in some cAMP-related mechanism.